bioAffinity Technologies, Inc.(BIAF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIAF bioAffinity Technologies, Inc.

休市中 09-04 16:00:00 EDT

15.27

+2.49

+19.48%

盘后10.36

-4.91-32.15%

19:59 EDT

最高20.35	最低10.90	成交量2,009万
今开11.12	昨收12.78	日振幅73.94%
总市值904.55万	流通市值896.14万	总股本59.24万
成交额3.41亿	换手率3,422.44%	流通股本58.69万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIAF","market":"US","secType":"STK","nameCN":"bioAffinity Technologies, Inc.","latestPrice":15.27,"timestamp":1788552000000,"preClose":12.78,"halted":0,"volume":20085150,"hourTrading":{"tag":"盘后","latestPrice":10.36,"preClose":15.27,"latestTime":"19:59 EDT","volume":1305047,"amount":17228000.6763,"timestamp":1788566399418,"change":-4.91,"changeRate":-0.321546,"amplitude":0.371316},"delay":0,"changeRate":0.19483568075117375,"floatShares":586866,"shares":592373,"eps":-103.3536,"marketStatus":"休市中","change":2.49,"latestTime":"09-04 16:00:00 EDT","open":11.12,"high":20.3499,"low":10.9,"amount":341371387.1112,"amplitude":0.739429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-103.3536,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":12.78,"preHourTrading":{"tag":"盘前","latestPrice":11.1204,"preClose":12.78,"latestTime":"09:29 EDT","volume":90893,"amount":1059635.320436,"timestamp":1788528599306,"change":-1.6596,"changeRate":-0.129859,"amplitude":0.119718},"postHourTrading":{"tag":"盘后","latestPrice":10.36,"preClose":15.27,"latestTime":"19:59 EDT","volume":1305047,"amount":17228000.6763,"timestamp":1788566399418,"change":-4.91,"changeRate":-0.321546,"amplitude":0.371316},"volumeRatio":0.898578},"requestUrl":"/m/hq/s/BIAF","defaultTab":"news","newsList":[{"id":"1190500452","title":"bioAffinity Technologies宣布1比15反向股票拆分，将于2026年8月24日开盘时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1190500452","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190500452?lang=zh_cn&edition=full","pubTime":"2026-08-20 20:01","pubTimestamp":1787227281,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc.今日正式宣告，其先前披露的1比15反向股票拆分计划，已确定于2026年8月24日美股开盘之际正式落地。此举意味着，每15股现有普通股将自动合并为1股新股，公司总股本相应大幅缩减，而每股股价则按比例抬升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139","BIAFW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139786761","title":"bioAffinity Technologies 宣布完成400万美元定向增发，按纳斯达克规则市价发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1139786761","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139786761?lang=zh_cn&edition=full","pubTime":"2026-08-14 23:08","pubTimestamp":1786720088,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc.宣告，其按照纳斯达克规则以市价定价的400万美元私募配售已正式结束。此次发行圆满收官，为公司注入了新的资金活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF","BIAFW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130138033","title":"bioAffinity Technologies 宣布完成400万美元市价私募配售定价，符合纳斯达克规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1130138033","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130138033?lang=zh_cn&edition=full","pubTime":"2026-08-13 21:12","pubTimestamp":1786626754,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc. 今日正式对外宣布，其规模达400万美元的市价私募配售已成功完成定价。此次发行严格遵循纳斯达克市场规则，以现行市场价格进行交易。这是一次备受瞩目的资本运作，为公司未来发展注入了新的活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176989506","title":"bioAffinity Technologies公布积极临床前结果：专有基因沉默技术选择性杀伤鳞状皮肤癌细胞，不损伤健康细胞","url":"https://stock-news.laohu8.com/highlight/detail?id=1176989506","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176989506?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:06","pubTimestamp":1782129966,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies公司报告了积极的临床前研究结果，其专有的基因沉默技术展现出了对鳞状皮肤癌细胞的细胞毒性，同时不会对健康细胞造成伤害。这项技术显示出高度的选择性，为针对此类癌症的精准疗法开发提供了新的可能性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134036435","title":"bioAffinity Technologies宣布旗舰肺癌诊断产品Cypath® Lung在2025年创下营收与销量新纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=1134036435","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134036435?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:02","pubTimestamp":1773403339,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies公司今日公布，其旗舰产品——肺癌诊断方案Cypath® Lung在2025年实现了创纪录的营收表现与单位销量。这一里程碑标志着该诊断工具在市场上的强劲增长和广泛认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158495268","title":"bioAffinity Technologies启动其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1158495268","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158495268?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:49","pubTimestamp":1773143344,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies公司宣布，已启动一项针对其非侵入性Cypath®肺癌诊断技术的大规模纵向临床研究。该研究旨在通过长期跟踪和数据收集，进一步验证该诊断方法的有效性与可靠性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518276192","title":"Bioaffinity Technologies, Inc.盘中异动 早盘股价大涨7.67%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518276192?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:50","pubTimestamp":1741618251,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时50分，Bioaffinity Technologies, Inc.股票出现波动，股价大幅上涨7.67%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为0.23%。其相关个股中，Bioaffinity Technologies, Inc.、恩佐生化、23Andme Holding Co.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Grail, Inc.较为活跃，换手率分别为6.12%、2.70%、2.01%，振幅较大的相关个股有Inotiv, Inc.、23Andme Holding Co.、Exagen Inc.，振幅分别为20.23%、16.77%、15.17%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225051a26a430d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310225051a26a430d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910702","title":"Bioaffinity Technologies, Inc.盘中异动 早盘大幅上涨5.15%报0.347美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910702?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:34","pubTimestamp":1741185287,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时34分，Bioaffinity Technologies, Inc.股票出现异动，股价快速上涨5.15%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.04%。其相关个股中，Neuronetics, Inc.、Radnet, Inc.、Genedx Holdings Corp.涨幅较大，Ispecimen Inc.、Endra Life Sciences Inc.、Neuronetics, Inc.较为活跃，换手率分别为0.62%、0.60%、0.51%，振幅较大的相关个股有Biodesix, Inc.、Neuronetics, Inc.、Oncocyte Corporation，振幅分别为9.15%、8.82%、6.26%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223447989d46a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223447989d46a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516939634","title":"Bioaffinity Technologies, Inc.盘中异动 早盘急速下挫8.00%报0.460美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516939634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516939634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:35","pubTimestamp":1741012524,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时35分，Bioaffinity Technologies, Inc.股票出现异动，股价大幅下挫8.00%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为0.72%。其相关个股中，Biodesix, Inc.、Endra Life Sciences Inc.、Neuronetics, Inc.涨幅较大，23Andme Holding Co.、Prophase Labs, Inc.、Ispecimen Inc.较为活跃，换手率分别为3.35%、0.98%、0.87%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、安奈特保险、Biodesix, Inc.，振幅分别为20.35%、9.00%、7.30%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032235249637ad36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032235249637ad36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BIAF","BDSX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514373893","title":"Bioaffinity Technologies, Inc.盘中异动 早盘大幅拉升7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514373893?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:52","pubTimestamp":1740754366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时52分，Bioaffinity Technologies, Inc.股票出现波动，股价大幅拉升7.12%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为0.04%。其相关个股中，Opko健康、Fulgent Genetics, Inc.、Personalis, Inc.涨幅较大，Ispecimen Inc.、Prophase Labs, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为5.47%、1.84%、1.82%，振幅较大的相关个股有Personalis, Inc.、Castle Biosciences, Inc.、Fulgent Genetics, Inc.，振幅分别为13.44%、13.09%、12.27%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822524696341ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822524696341ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514383041","title":"Bioaffinity Technologies, Inc.盘中异动 早盘大幅下跌8.81%报0.527美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514383041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514383041?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666904,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分，Bioaffinity Technologies, Inc.股票出现波动，股价急速跳水8.81%。截至发稿，该股报0.527美元/股，成交量1.254万股，换手率0.08%，振幅4.86%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为0.96%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223504a2567aea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223504a2567aea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385924","title":"Bioaffinity Technologies, Inc.盘中异动 早盘急速下跌5.54%报0.614美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385924?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:46","pubTimestamp":1740581208,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时46分，Bioaffinity Technologies, Inc.股票出现波动，股价快速下挫5.54%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.09%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Endra Life Sciences Inc.涨幅较大，Prophase Labs, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为4.71%、2.04%、1.29%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prophase Labs, Inc.、Bioaffinity Technologies, Inc.，振幅分别为25.74%、10.61%、9.23%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224648abddf0f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224648abddf0f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514309037","title":"Bioaffinity Technologies, Inc.盘中异动 急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514309037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514309037?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493959,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Bioaffinity Technologies, Inc.股票出现异动，股价大幅上涨5.45%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为0.20%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prenetics Global、Bioaffinity Technologies, Inc.涨幅较大，Ispecimen Inc.、Prophase Labs, Inc.、Check-Cap Ltd.较为活跃，换手率分别为16.56%、6.41%、0.90%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、万基遗传、Veracyte, Inc.，振幅分别为31.96%、11.25%、9.52%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522323998924ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522323998924ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514705679","title":"Bioaffinity Technologies, Inc.盘中异动 快速下跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514705679?lang=zh_cn&edition=full","pubTime":"2025-02-25 05:00","pubTimestamp":1740430832,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日05时00分，Bioaffinity Technologies, Inc.股票出现波动，股价快速跳水6.02%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.58%。其相关个股中，Check-Cap Ltd.、Ispecimen Inc.、Endra Life Sciences Inc.涨幅较大，Ispecimen Inc.、Check-Cap Ltd.、Prophase Labs, Inc.较为活跃，换手率分别为2596.24%、111.03%、15.37%，振幅较大的相关个股有Check-Cap Ltd.、Ispecimen Inc.、Genedx Holdings Corp C/Wts 22/07/2026 ，振幅分别为83.95%、63.16%、52.80%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225050033abdb5ef7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225050033abdb5ef7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512822254","title":"Bioaffinity Technologies, Inc.盘中异动 快速拉升6.37%报0.836美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512822254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512822254?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:01","pubTimestamp":1739984492,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时01分，Bioaffinity Technologies, Inc.股票出现波动，股价急速拉升6.37%。截至发稿，该股报0.836美元/股，成交量2.3907万股，换手率0.15%，振幅4.11%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.93%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220010133988b49a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220010133988b49a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510886349","title":"Bioaffinity Technologies, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510886349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510886349?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:30","pubTimestamp":1739197857,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时30分，Bioaffinity Technologies, Inc.股票出现异动，股价大幅上涨5.13%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.00%。其相关个股中，安奈特保险、Prenetics Global、Precipio, Inc.涨幅较大，Inotiv, Inc.、Mainz Biomed N.V.、Neuronetics, Inc.较为活跃，换手率分别为0.42%、0.41%、0.25%，振幅较大的相关个股有Inotiv, Inc.、Bioaffinity Technologies, Inc.、Neogenomics, Inc.，振幅分别为7.98%、2.46%、1.67%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223057988077ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223057988077ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509645744","title":"Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509645744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509645744?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:35","pubTimestamp":1738938938,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时35分，Bioaffinity Technologies, Inc.股票出现波动，股价大幅下挫5.95%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为1.06%。其相关个股中，梅特勒-托利多、Exagen Inc.、Prophase Labs, Inc.涨幅较大，Neuronetics, Inc.、Guardant Health, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为4.46%、1.56%、1.24%，振幅较大的相关个股有安奈特保险、Neuronetics, Inc.、T2 Biosystems, Inc.，振幅分别为9.11%、7.02%、5.76%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223538abc62b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223538abc62b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509002207","title":"Bioaffinity Technologies, Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509002207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509002207?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:40","pubTimestamp":1738867223,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时40分，Bioaffinity Technologies, Inc.股票出现波动，股价急速跳水5.51%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为1.24%。其相关个股中，Genedx Holdings Corp C/Wts 22/07/2026 、Neuronetics, Inc.、Endra Life Sciences Inc.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、T2 Biosystems, Inc.较为活跃，换手率分别为15.09%、13.74%、4.16%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Mainz Biomed N.V.、Prophase Labs, Inc.，振幅分别为25.50%、14.00%、13.63%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207024023a23c0113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207024023a23c0113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509235744","title":"Bioaffinity Technologies, Inc.盘中异动 早盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509235744?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:19","pubTimestamp":1738772391,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时19分，Bioaffinity Technologies, Inc.股票出现波动，股价大幅上涨5.04%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体涨幅为0.16%。其相关个股中，Grail, Inc.、Exagen Inc.、Prophase Labs, Inc.涨幅较大，Mainz Biomed N.V.、Genedx Holdings Corp.、Ispecimen Inc.较为活跃，换手率分别为15.90%、10.69%、3.64%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Genedx Holdings Corp.、Exagen Inc.，振幅分别为22.77%、21.91%、21.70%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600195196191bda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600195196191bda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508297128","title":"Bioaffinity Technologies, Inc.盘中异动 早盘股价大跌8.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508297128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508297128?lang=zh_cn&edition=full","pubTime":"2025-02-04 00:28","pubTimestamp":1738600099,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日00时28分，Bioaffinity Technologies, Inc.股票出现波动，股价大幅下挫8.62%。Bioaffinity Technologies, Inc.股票所在的生命科学行业中，整体跌幅为0.12%。其相关个股中，Mainz Biomed N.V.、爱德士、T2 Biosystems, Inc.涨幅较大，Prophase Labs, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为41.96%、15.92%、9.78%，振幅较大的相关个股有Mainz Biomed N.V.、Prophase Labs, Inc.、T2 Biosystems, Inc.，振幅分别为27.91%、18.42%、12.93%。Bioaffinity Technologies, Inc.公司简介：bioAffinity Technologies Inc 致力于解决早期癌症和肺部疾病无创诊断以及靶向癌症治疗的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020400281996170dcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020400281996170dcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioaffinitytech.com;ir.bioaffinitytech.com","stockEarnings":[{"period":"1week","weight":2.1355},{"period":"1month","weight":0.9215},{"period":"3month","weight":-0.4116},{"period":"6month","weight":-0.0212},{"period":"1year","weight":-0.8581},{"period":"ytd","weight":-0.1373}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"bioAffinity Technologies, Inc.于2014年3月26日作为特拉华州公司成立。该公司开发非侵入性诊断测试，主要利用流式细胞术和人工智能驱动的分析，用于早期肺癌和其他呼吸系统疾病。其主要商业检测产品CyPath Lung通过其获得CAP认可的实验室子公司提供，同时也在推进癌症治疗的疗法研究。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.125018},{"month":2,"riseRate":0.25,"avgChangeRate":-0.070787},{"month":3,"riseRate":0.5,"avgChangeRate":0.528916},{"month":4,"riseRate":0.75,"avgChangeRate":0.175283},{"month":5,"riseRate":0,"avgChangeRate":-0.203542},{"month":6,"riseRate":0.25,"avgChangeRate":-0.147014},{"month":7,"riseRate":0.5,"avgChangeRate":-0.002263},{"month":8,"riseRate":0,"avgChangeRate":-0.291593},{"month":9,"riseRate":0.5,"avgChangeRate":0.453903},{"month":10,"riseRate":0.25,"avgChangeRate":-0.105345},{"month":11,"riseRate":0.25,"avgChangeRate":-0.068737},{"month":12,"riseRate":0,"avgChangeRate":-0.246482}],"exchange":"NASDAQ","name":"bioAffinity Technologies, Inc.","nameEN":"bioAffinity Technologies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"bioAffinity Technologies, Inc.(BIAF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供bioAffinity Technologies, Inc.(BIAF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"bioAffinity Technologies, Inc.,BIAF,bioAffinity Technologies, Inc.股票,bioAffinity Technologies, Inc.股票老虎,bioAffinity Technologies, Inc.股票老虎国际,bioAffinity Technologies, Inc.行情,bioAffinity Technologies, Inc.股票行情,bioAffinity Technologies, Inc.股价,bioAffinity Technologies, Inc.股市,bioAffinity Technologies, Inc.股票价格,bioAffinity Technologies, Inc.股票交易,bioAffinity Technologies, Inc.股票购买,bioAffinity Technologies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"bioAffinity Technologies, Inc.(BIAF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供bioAffinity Technologies, Inc.(BIAF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}